Subsidiary AP Biosciences and Tasly Biopharmaceuticals Signed Cooperative Development and Authorized Agreement of New Antibody Drug

Announcement on the Change of Spokesperson

Announcement of New CEO

Announcement of 3rd Audit Committee Members

Announcement of 4th Payroll Committee Members

Taiwan Shilin District Court appeals against the acquittal of Mr. Michael Chang and five other executives’insider trading case

Supplementary statement regarding the news article by the Investor and other news media

Announcement of the status of implementation of the commitments during the up-listing at over-the-counter market

Company’s Board of Directors nominated Michael Chang to serve as the Chairman of the Board

Announcement to Permit Competitive Conduct by Officers